A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/129
A61K 35/74 (2006.01) C07K 14/235 (2006.01)
Patent
CA 1114293
ABSTRACT The Leukocytosis Promoting Factor (LPF) of Bordetella haemagglutinin (HG) is separated from crude cell supernatant or partially purified protein by affinity chromatography on a column material consisting of an insoluble polymeric support to which is bound a sialoprotein (glycoprotein containing sialic acid) or other substance rich in sialic acid. The sialoprotein was preferably a plasma sialoprotein such as haptoglobin or ceruloplasmin or a salivary mucin, and the polymeric support was preferably an agarose gel, though other conventional sup- ports could be used. By this process, on treatment of an ammonium sulphate pre- cipitated extract, the haemagglutinating activity may be increased 300-600 fold over the extract and 10,000 times over the crude centrifuged cell supernatant. Alternatively a fraction substantially free from LPF-HG may be collected. Pertus- sis LPF-HG is reported to have various useful clinical properties, in particular adjuvant effect on antigenicity and the abilities to induce leukocytosis and sensitivity to histamine. By the process of the present invention LPF-HG may be produced cheaply and in large quantities or removed from other cell extracts.
322553
Irons Laurence I.
Maclennan Alastair P.
Fetherstonhaugh & Co.
The Microbiological Research Authority
LandOfFree
Purification of pertussis haemagglutinins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purification of pertussis haemagglutinins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purification of pertussis haemagglutinins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1092954